Dengue virus capsid protein interacts specifically with very low-density lipoproteins

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 247-255

  Faustino, André F ^a   Carvalho, Filomena A ^a   Martins, Ivo C ^a   Castanho, Miguel A R B ^a   Mohana Borges, Ronaldo ^b   Almeida, Fábio C L ^b   Da Poian, Andrea T ^b   Santos, Nuno C ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

AFM based force spectroscopy; Dengue virus capsid protein; Dynamic light scattering; Lipoproteins; Single molecule studies

Indexed keywords

CELLULAR STRUCTURE; COMPUTATIONAL ANALYSIS; DENGUE VIRUS; FORCE SPECTROSCOPY; LOW DENSITY LIPOPROTEINS; SINGLE-MOLECULE STUDIES; THERAPEUTIC INTERVENTION; VERY LOW DENSITY LIPOPROTEINS;

ATOMIC FORCE MICROSCOPY; COMPUTATIONAL METHODS; DYNAMIC LIGHT SCATTERING; LIFE CYCLE; POTASSIUM; SPECTROSCOPY; VIRUSES;

LIPOPROTEINS;

AMINO ACID; APOLIPOPROTEIN E; CAPSID PROTEIN; FAT DROPLET; LOW DENSITY LIPOPROTEIN; PERILIPIN; PERILIPIN 3; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; CONTROLLED STUDY; DENGUE VIRUS; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HISTOGRAM; HYDRODYNAMICS; LIGHT SCATTERING; MOLECULAR RECOGNITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPECTROSCOPY;

DENGUE VIRUS; MIRIDAE;

AFM; AFM-BASED FORCE SPECTROSCOPY; APOE; APOLIPOPROTEIN E; ATOMIC FORCE MICROSCOPY; CΑ RMSD; D(H); DENGUE VIRUS; DENGUE VIRUS CAPSID PROTEIN; DENV; DENV C; DLS; DYNAMIC LIGHT SCATTERING; HCV; HEPATITIS C VIRUS; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HSQC; HYDRODYNAMIC DIAMETER; LD; LDL; LDLR; LIPID DROPLET; LIPOPROTEINS; LIPOVIROPARTICLES; LOW-DENSITY LIPOPROTEIN; LOW-DENSITY LIPOPROTEIN RECEPTOR; LVP; NMR; NUCLEAR MAGNETIC RESONANCE; SINGLE-MOLECULE STUDIES; VERY LOW-DENSITY LIPOPROTEIN; VLDL; Α-CARBONS ROOT MEAN SQUARED DEVIATION;

CAPSID PROTEINS; DENGUE; DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPOPROTEINS, VLDL; POTASSIUM; PROTEIN BINDING; VIRION;

EID: 84891022612     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.06.004     Document Type: Article

References (43)

1. Guzman A., Isturiz R.E. Update on the global spread of dengue. Int J Antimicrob Agents 2010, 36:S40-S42.
2. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010, 8:S7-S16.
3. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
4. Gubler D.J. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med Singapore 1998, 27:227-234.
5. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002, 10:100-103.
6. Enserink M. Infectious diseases. Yellow fever mosquito shows up in northern Europe. Science 2010, 329:736.
7. Lambrechts L., Scott T.W., Gubler D.J. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 2010, 4:e646.
8. Reiter P. Yellow fever and dengue: a threat to Europeα. Euro Surveill 2010, 15:19509.
9. Sousa C.A., Clairouin M., Seixas G., Viveiros B., Novo M.T., Silva A.C., et al. Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report. Euro Surveill 2012, 17:20333.
10. Alves M.J., Fernandes P.L., Amaro F., Osório H., Luz T., Parreira P., et al. Clinical presentation and laboratory findings for the first autochthonous cases of dengue fever in Madeira island, Portugal, October 2012. Euro Surveill 2013, 18:20398.
11. Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005, 3:13-22.
12. Schweitzer B.K., Chapman N.M., Iwen P.C. Overview of the Flaviviridae with an emphasis on the Japanese encephalitis group viruses. Labmedicine 2009, 40:493-499.
13. Fujie H., Yotsuyanagi H., Moriya K., Shintani Y., Tsutsumi T., Takayama T., et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 1999, 59:141-145.
14. Quaresma J.A., Barros V.L., Pagliari C., Fernandes E.R., Andrade H.F., Vasconcelos P.F., et al. Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg 2007, 101:161-168.
15. Seneviratne S.L., Malavige G.N., de Silva H.J. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006, 100:608-614.
16. Suvarna J.C., Rane P.P. Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop Med Int Health 2009, 14:576-585.
17. van Gorp E.C., Suharti C., Mairuhu A.T., Dolmans W.M., van Der Ven J., Demacker P.N., et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis 2002, 34:1150-1153.
18. Agnello V., Abel G., Elfahal M., Knight G.B., Zhang Q.X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999, 96:12766-12771.
19. Andre P., Komurian-Pradel F., Deforges S., Perret M., Berland J.L., Sodoyer M., et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002, 76:6919-6928.
20. Bartenschlager R., Penin F., Lohmann V., Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011, 19:95-103.
21. Clark K.B., Hsiao H.M., Noisakran S., Tsai J.J., Perng G.C. Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med 2012, 85:3-18.
22. Carvalho F.A., Carneiro F.A., Martins I.C., Assunção-Miranda I., Faustino A.F., Pereira R.M., et al. Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J Virol 2012, 86:2096-2108.
23. Ma L., Jones C.T., Groesch T.D., Kuhn R.J., Post C.B. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci U S A 2004, 101:3414-3419.
24. Martins I.C., Gomes-Neto F., Faustino A.F., Carvalho F.A., Carneiro F.A., Bozza P.T., et al. The disordered N-terminal region of dengue virus capsid protein contains a drug targetable lipid droplet-binding motif. Biochem J 2012, 444:405-415.
25. Samsa M.M., Mondotte J.A., Iglesias N.G., Assunção-Miranda I., Barbosa-Lima G., Da Poian A.T., et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 2009, 5:e1000632.
26. Carvalho F.A., Connell S., Miltenberger-Miltenyi G., Pereira S.V., Tavares A., Ariëns R.A.S., et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano 2010, 4:4609-4620.
27. Carvalho F.A., Santos N.C. Atomic force microscopy-based force spectroscopy - biological and biomedical applications. IUBMB Life 2012, 64:465-472.
28. Martins I.C., Santos N.C., Almeida F.C.L., Da Poian A.T. DENV-derived peptides for the inhibition of the Flavivirus replication. Patent Cooperation Treaty (PCT) 2012, Pub. No.: WO/2012/159187.
29. Kahlon T.S., Shore V.G., Lindgren F.T. Heterogeneity of molecular-weight and apolipoproteins in low-density lipoproteins of healthy-human males. Lipids 1992, 27:1055-1057.
30. Berne B.J., Pecora R. Dynamic light scattering - with application to chemistry, biology and physics 1990, Krieger Publishing Company, Melbourne, Australia. E R (Ed.).
31. Santos N.C., Castanho M.A.R.B. Teaching light scattering spectroscopy: the dimension and shape of tobacco mosaic virus. Biophys J 1996, 71:1641-1650.
32. Provencher S.W. A constrained regularization method for inverting data represented by linear algebraic or integral-equations. Comp Phys Commun 1982, 27:213-227.
33. Provencher S.W. CONTIN - a general-purpose constrained regularization program for inverting noisy linear algebraic and integral-equations. Comp Phys Commun 1982, 27:229-242.
34. Malvern Instruments Ltd. Zetasizer nano series. Malvern Instruments User Manual 2004.
35. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995, 6:277-293.
36. Johnson B.A., Blevins R.A. NMR View: a computer program for the visualization and analysis of NMR data. J Biomol NMR 1994, 4:603-614.
37. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612.
38. Sanner M.F., Olson A.J., Spehner J.C. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 1996, 38:305-320.
39. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003, 31:3497-3500.
40. Cushley R.J., Okon M. NMR studies of lipoprotein structure. Annu Rev Biophys Biomol Struct 2002, 31:177-206.
41. Wood R.J., Volek J.S., Liu Y., Shachter N.S., Contois J.H., Fernandez M.L. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. J Nutr 2006, 136:384-389.
42. Nelson D.L., Cox M.M. Lehninger principles of biochemistry 2005, W.H. Freeman & Co Ltd. Fourth Ed.
43. Hickenbottom S.J., Kimmel A.R., Londos C., Hurley J.H. Structure of a lipid droplet protein; the PAT family member TIP47. Structure 2004, 12:1199-1207.